Home / Denmark / Trifork Group AG
Trifork Group AG
No short position is open on this share today.
0.00% of the capital sold short
0 disclosing funds
6 disclosures on record
Open positions
No fund discloses a short position on this share today. The history below keeps the trace of the ones that existed.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| November 11, 2022 | J.P. Morgan Asset Management (UK) Limited | 0.33% | November 11, 2022 |
| August 1, 2022 | J.P. Morgan Asset Management (UK) Limited | 0.51% | August 1, 2022 |
| July 21, 2022 | J.P. Morgan Asset Management (UK) Limited | 0.48% | July 21, 2022 |
| June 14, 2022 | J.P. Morgan Asset Management (UK) Limited | 0.51% | June 14, 2022 |
| May 4, 2022 | J.P. Morgan Asset Management (UK) Limited | 0.49% | May 4, 2022 |
| April 25, 2022 | J.P. Morgan Asset Management (UK) Limited | 0.51% | April 25, 2022 |
Other companies sold short in Denmark
- Zealand Pharma A/S 6.75% of the capital sold short
- GN Store Nord A/S 4.81% of the capital sold short
- Ambu A/S 4.00% of the capital sold short
- Pandora A/S 2.25% of the capital sold short
- Carlsberg A/S 1.90% of the capital sold short
- Demant A/S 1.89% of the capital sold short
- Netcompany Group A/S 1.58% of the capital sold short
- Aquaporin A/S 1.51% of the capital sold short
- Matas A/S 1.28% of the capital sold short
- Noble Corporation Plc 1.17% of the capital sold short
- Novozymes A/S 1.00% of the capital sold short
- ChemoMetec A/S 0.92% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Trifork Group AG, source Finanstilsynet, data as at November 11, 2022, https://www.quivad.com/action/trifork-group-ag